可注射型心肌组织工程技术研究进展
摘要
据WHO估计全球范围内29％死亡归因于冠心病及心肌梗死导致的心力衰竭（心衰），目前药物治疗及左心室辅助装置植入只能延缓心衰进展，并不能明显改善预后。终末期心衰患者可进行心脏移植，然而由于器官移植供体来源紧张和终生服用抗排斥药物及相关的免疫抑制剂带来的各种并发症等原因使其无法满足临床诊治的需要。
出处
《中华心血管病杂志》
CAS
CSCD
北大核心
2013年第3期262-264,共3页
Chinese Journal of Cardiology
参考文献40
-
1Kirkpatrick JN, Wiegers SE, Lang RM. Left ventricular assist devices and other devices for end-stage heart failure echocardiography. Curt" Cardiol Rep,2010,12:257-264.
-
2Boilson BA, Raichlin E, Park SJ, et al. Device therapy and cardiac transplantation for end-stage heart failure. Curr Probl Cardiol, 2010,35:8-64.
-
3Zandonella C. Tissue engineering: the beat goes on. Nature, 2003,421 : 884 -886.
-
4Christman KL, Lee RJ. Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol,2006,48:907-913.
-
5Gimble JM. Adipose tissue-derived therapeutics. Expert Opin Biol Ther, 2003,3:705-713.
-
6Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res,2007,100 : 1249-1260.
-
7Kehat I, Kenyagin-Karsenti D, Snir M, et al. Human embryonic stem cells era1 differentiate into myocytes with structural and functional properties of eardiomyocytes. J Clin Invest, 2001,108: 407-414.
-
8Laflamme MA, Gold J, Xu C, et al. Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol,2005,167:663-671.
-
9Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature, 2008,451:937-942.
-
10Wakayama T, Tabar V, Rodriguez I, et al. Differentiation of embryonic stem cell lines generated from adult somatic ceils by nuclear transfer. Science, 2001,292:740-743.
二级参考文献19
-
1徐斌,卢文宁,郝彤,吕双红,王常勇.壳聚糖水凝胶局部注射对心梗的治疗作用研究[J].解放军医学杂志,2007,32(5):493-495. 被引量：6
-
2Jugdutt BI. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation, 2003, 108 : 1395-1403.
-
3Sun Y, Weber KT. Infarct scar: a dynamic tissue. Cardiovasc Res, 2000, 46: 250-256.
-
4Dai W, Wold LE, Dow JS, et al. Thickening of the infarcted wall by collagen injection improves left ventricular function in ratsa novel approach to preserve cardiac function after myocardial infarction. J Am Coll Cardiol, 2005, 46: 714-719.
-
5Christman KL, Fok HH, Sievers RE, et al. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng, 2004, 10: 403-409.
-
6Peppas NA, Huang Y, Tortes LM, et al. Physicochemical foundations and structural design of hydrogels in medicine and biology. Annu Rev Biomed Eng, 2000, 2 : 9-29.
-
7Wu DQ, Wang T, Lu B, et al. Fabrication of supramolecular hydrogels for drug delivery and stem cell encapsulation. Langmuir, 2008, 24: 10306-10312.
-
8Kudo M, Wang Y, Wani MA, et al. Implantation of bone marrow stem ceUs reduces the infarction and fibrosis in ischemic mouse heart. J Mol Cell Cardiol, 2003, 35: 1113-1119.
-
9Dresske B, Mokhtari NE, Ungefroren H, et al. Multipotent cells of monocytic origin improve damaged heart function. Am J Transplant,2006, 6: 947-958.
-
10Christman KL, Lee R.J. Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol, 2006, 48:907-913.
-
1做过器官移植者更易患非典[J].传染病网络动态,2003(9):12-12.
-
2康子妮.环孢霉素可减轻心肌梗塞患者的心肌损伤[J].心血管病防治知识,2008(10):28-28.
-
3何国祥.心原性休克的血流动力学支持——经皮左心室辅助装置[J].临床心血管病杂志,2013,29(5):324-327.
-
4高珊,刘克坚,邱强.冠心病诊断技术研究进展[J].中华实用诊断与治疗杂志,2010,24(4):318-320. 被引量：19
-
5路钟华,余小宝.流行性出血热实验诊断技术研究进展[J].宜春医药,1989(1):34-36.
-
6黄铮,刘伊丽.血管内超声技术研究进展[J].中国介入心脏病学杂志,1997,5(2):94-96.
-
7任丽楠,郭晓钟,崔忠敏,邹德莉.70例药物性肝病的临床特点分析[J].辽宁医学杂志,2011,25(1):17-18. 被引量：6
-
8Klotz S.,Barbone A.,Reiken S.,D. Burkhoff,腾增辉.左心室辅助装置促进左、右心室β肾上腺素能通路反应性的正常化[J].世界核心医学期刊文摘（心脏病学分册）,2005,0(8):51-51. 被引量：3
-
9曲孝章,刘全.左心室辅助装置的现状及展望[J].吉林医学,2008,29(7):608-610.
-
10张斌,马墩亮.左心室辅助装置在高危冠状动脉介入治疗中的应用[J].循证医学,2013,13(6):326-329. 被引量：2
